Raymond James Financial Services Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-33,900
Closed -$25K 2964
2018
Q2
$25K Sell
33,900
-73,500
-68% -$6.1M ﹤0.01% 2715
2018
Q1
$19K Buy
107,400
+95,400
+795% +$9.16M ﹤0.01% 2500
2017
Q4
$1K Sell
12,000
-95,000
-89% -$10.7M ﹤0.01% 2532
2017
Q3
$514K Sell
107,000
-7,300
-6% -$994K ﹤0.01% 1699
2017
Q2
$323K Buy
114,300
+9,100
+9% +$1.12M ﹤0.01% 1955
2017
Q1
$21K Buy
105,200
+62,200
+145% +$7.44M ﹤0.01% 2370
2016
Q4
$3K Sell
43,000
-42,800
-50% -$4.77M ﹤0.01% 2342
2016
Q3
$29K Buy
85,800
+18,700
+28% +$2.02M ﹤0.01% 2232
2016
Q2
$6K Sell
67,100
-67,100
-50% -$6.94M ﹤0.01% 2273
2016
Q1
$11K Buy
+134,200
New +$13.8M ﹤0.01% 2055

Other funds holding CELG

Raymond James Financial Services Advisors's CELG Position: Q4 2019 in Review

Raymond James Financial Services Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 116,649 shares — an estimated $11.6M sold.

Raymond James Financial Services Advisors first reported a position in CELG in Q2 2013 and held it in 19 quarters. The position peaked at $80.6M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Raymond James Financial Services Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 116,649 Celgene Corp shares in Q4 2019, an estimated $11.6M.
  • Raymond James Financial Services Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 19 quarters.
  • Raymond James Financial Services Advisors's Celgene Corp position peaked at $80.6M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2019, filed 12 Feb 2020.